Generic Name and Formulations:
Sodium hyaluronate 5000 10mg/mL; viscoelastic soln for intraocular use.
Indications for HEALON:
Inject through a fine cannula into the eye. Amount varies depending on surgery, repeated inj may be required. Total amount is usually <1mL in anterior segment surgery.
Single use only; reuse may cause inflammatory reaction. Glaucoma; consider prophylactic pressure-lowering treatment. Complete removal of soln necessary to avoid intraocular pressure peaks post-op.
Ophthalmic viscosurgical device.
Incompatibility, resulting in opalescence, between sodium hyaluronate and solutions containing quaternary ammonium ions (eg, detergents, benzalkonium chloride).
Transient rise in intraocular pressure, myopic shift (if product not completely removed).
Endocrinology Advisor Articles
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Trends in Bisphosphonate Use and Hip Fracture Rates in Denmark
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
- FDA Committee Votes on Oral T1D Treatment Sotagliflozin
- Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
- Therapeutic Effect of Long-Chain PUFA Omega 3 Supplementation in Obese Children
- Poor Health Outcomes Associated With Fear of Crime, Violence Among College Students of Color
- Safety of PCSK9 Inhibitors After Heart Transplantation Examined